Health Care

Merck says experimental RSV shot protected infants in trial, paving way for potential approval

Merck is discussing the study data with regulators worldwide, with a goal of making the treatment available for infants as early as the 2025 to 2026 RSV season.

adminadmin
Oct 25, 2024 - 02:00
 0  7
Merck says experimental RSV shot protected infants in trial, paving way for potential approval
Merck is discussing the study data with regulators worldwide, with a goal of making the treatment available for infants as early as the 2025 to 2026 RSV season.
Read More

Tags:

Previous Article

Chinese smartphone maker Oppo doubles down on AI, says in regular talks with Goo...

Next Article

FDA eyes McDonald's supplier Taylor Farms as source of E. Coli outbreak

admin
admin

Related Posts

Samsung launches the Galaxy Ring — a first-of-its-kind product for the tech giant

Samsung launches the Galaxy Ring — a first-of-its-kind ...

admin Jul 10, 2024  0  14

CDC issues dengue fever alert in the U.S.

CDC issues dengue fever alert in the U.S.

admin Jun 26, 2024  0  15

Weight loss drugs like Wegovy could spawn a host of new piggyback product lines

Weight loss drugs like Wegovy could spawn a host of new...

admin Jun 8, 2024  0  6